跳至主要内容
临床试验/ITMCTR2026001714
ITMCTR2026001714进行中(未招募)Unknown

Randomized Controlled, Double-Blind, Double-Simulated Study on Qianlie Tongluo Decoction in the Treatment of Type III Chronic Nonbacterial Prostatitis with Damp-Heat Stasis Syndrome

Dongzhimen Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 2026年7月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 50(—)
性别
Male

入选标准

  • (1) Male patients meeting the Western medicine diagnostic criteria for type III prostatitis;
  • (2) NIH-CPSI score > 10 points;
  • (3) Patients conforming to the syndrome differentiation standard of damp-heat stagnation and blood stasis syndrome;
  • (4) Patients with relevant symptoms consistent with diagnostic criteria lasting for more than 3 months;
  • (5) Aged from 18 to 50 years old (inclusive);
  • (6) No antibiotics or treatments for chronic prostatitis administered within 2 weeks before enrollment;
  • (7) No other medications taken by patients within two weeks prior to enrollment;
  • (8) Patients fully informed of the trial conditions and voluntarily signed the informed consent form.

排除标准

  • (1) Patients complicated with prostatic tumors, neurogenic bladder dysfunction, urethral malformation or stricture, and severe neurosis.
  • (2) Patients with urinary tract infection or urethritis.
  • (3) For patients presenting mainly with local pain, other diseases involving lower abdomen, perineum, lumbosacral region and other parts shall be excluded, such as ureteral or vesical calculi, inguinal hernia, pubic osteitis, varicocele, epididymitis, colorectal diseases, lumbodorsal fasciitis, etc.
  • (4) Patients complicated with severe primary diseases of cardiovascular and cerebrovascular systems, liver, kidney and hematopoietic system.
  • (5) Subjects participating in other clinical drug trials concurrently or taking drugs with similar therapeutic effects to the trial medication.
  • (6) Patients who use Chinese and Western medicines, health products, or herbal decoctions containing prescribed medicinal slices with therapeutic effects on this disease during the trial period.
  • (7) Patients with fertility requirements.

研究者

发起方
Dongzhimen Hospital, Beijing University of Chinese Medicine

相似试验